Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells.
E Platzer(Friedrich-Alexander-Universität Erlangen-Nürnberg), M A Moore(Memorial Sloan Kettering Cancer Center), Li Lu(Guangdong Pharmaceutical University), Paul E. Harris(Institute of Genetics and Biophysics), Roland Mertelsmann(Twitter (United States)), Janice Gabrilove(Memorial Sloan Kettering Cancer Center), Karl Welte(Medizinische Hochschule Hannover)
Cited by 171
Related Papers
Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells
|Science|1986|1.2k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
|Proceedings of the National Academy of Sciences|1985|522
Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology
|Annals of Hematology|2004|488